Neurobehavioral adaptations to methylphenidate: The issue of early adolescent exposure

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 8, 2011, Pages 1722-1739

  Marco, Eva M ^a   Adriani, Walter ^a   Ruocco, Lucia A ^b   Canese, Rossella ^a   Sadile, Adolfo G ^b   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

5 HT(7); ADHD; BOLD; Dorsal striatum; Genome wide; Impulsivity; Nucleus accumbens; PhMRI; Rat; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; ALCOHOL; CANNABINOID; COCAINE; DIAMORPHINE; DOPAMINE; METHYLPHENIDATE; NICOTINE; SEROTONIN; SEROTONIN TRANSPORTER; SODIUM CHLORIDE;

ADOLESCENT; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; BRAIN FUNCTION; BRAIN METABOLISM; CONDITIONING; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; DRUG EXPOSURE; DRUG SAFETY; EMOTIONALITY; EXPERIMENTAL MODEL; EXPLORATORY BEHAVIOR; FOREBRAIN; GENE; GENE EXPRESSION; HIGH RISK BEHAVIOR; HTR7 GENE; HUMAN; HYPERACTIVITY; NEUROBIOLOGY; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; REWARD; SELF CONTROL; SENSATION; STEREOTYPY; TOBACCO DEPENDENCE; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; ADOLESCENT DEVELOPMENT; ADULT; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CRITICAL PERIOD (PSYCHOLOGY); DISEASE MODELS, ANIMAL; HUMANS; METHYLPHENIDATE; MICE; RATS;

EID: 79960051220     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.02.011     Document Type: Review

References (214)

1. Accardo P., Blondis T.A. What's the fuss about Ritalin?. J. Pediatr. 2001, 138:6-9.
2. Adriani W., Leo D., Guarino M., Natoli A., Di Consiglio E., De Angelis G., Traina E., Testai E., Perrone-Capano C., Laviola G. Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in rats. Ann. N. Y. Acad. Sci. 2006, 1074:52-73.
3. Adriani W., Canese R., Podo F., Laviola G. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence. Neurotoxicol. Teratol. 2007, 29:116-125.
4. Adriani W., Chiarotti F., Laviola G. Elevated novelty seeking and peculiar d-amphetamine sensitization in periadolescent mice compared with adult mice. Behav. Neurosci. 1998, 112:1152-1166.
5. Adriani W., Deroche-Gamonet V., Le Moal M., Laviola G., Piazza P.V. Preexposure during or following adolescence differently affects nicotine-rewarding properties in adult rats. Psychopharmacology (Berl.) 2006, 184:382-390.
6. Adriani W., Laviola G. Spontaneous novelty seeking and amphetamine-induced conditioning and sensitization in adult mice: evidence of dissociation as a function of age at weaning. Neuropsychopharmacology 2002, 27:225-236.
7. Adriani W., Laviola G. Elevated levels of impulsivity and reduced place conditioning with d-amphetamine: two behavioral features of adolescence in mice. Behav. Neurosci. 2003, 117:695-703.
8. Adriani W., Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav. Pharmacol. 2004, 15:341-352.
9. Adriani W., Laviola G. Delay aversion but preference for large and rare rewards in two choice tasks: implications for the measurement of self-control parameters. BMC Neurosci. 2006, 7:52.
10. Adriani W., Leo D., Greco D., Rea M., di Porzio U., Laviola G., Perrone-Capano C. Methylphenidate administration to adolescent rats determines plastic changes on reward-related behavior and striatal gene expression. Neuropsychopharmacology 2006, 31:1946-1956.
11. Adriani W., Rea M., Baviera M., Invernizzi W., Carli M., Ghirardi O., Caprioli A., Laviola G. Acetyl-l-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology (Berl.) 2004, 176:296-304.
12. Adriani W., Zoratto F., Romano E., Laviola G. Cognitive impulsivity in animal models: role of response time and reinforcing rate in delay intolerance with two-choice operant tasks. Neuropharmacology 2010, 58:694-701.
13. Alexander G.E., Crutcher M.D., DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog. Brain Res. 1990, 85:119-146.
14. Ames A. CNS energy metabolism as related to function. Brain Res. Brain Res. Rev. 2000, 34:42-68.
15. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci. Biobehav. Rev. 2003, 27:3-18.
16. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., Carlezon W.A. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat. Neurosci. 2002, 5:13-14.
17. Andersen S.L., Gazzara R.A. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release. J. Neurochem. 1993, 61:2247-2255.
18. Andersen S.L., Thompson A.T., Rutstein M., Hostetter J.C., Teicher M.H. Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 2000, 37:167-169.
19. Anthony J.C., Petronis K.R. Early-onset drug use and risk of later drug problems. Drug Alcohol Depend. 1995, 40:9-15.
20. Arnett J. Reckless behavior in adolescence: a developmental perspective. Dev. Rev. 1992, 12:339-373.
21. Arria A.M., Wish E.D. Nonmedical use of prescription stimulants among students. Pediatr. Ann. 2006, 35:565-571.
22. Aspide R., Fresiello A., De Filippis G., Gironi Carnevale U.A., Sadile A.G. Non selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenidate and nitric oxide synthesis inhibitor treatment. Neurosci. Biobehav. Rev. 2000, 24:59-71.
23. Aspide R., Gironi Carnevale U.A., Sergeant J.A., Sadile A.G. Non-selective attention and nitric oxide in putative animal models of attention-deficit/hyperactivity disorder. Behav. Brain Res. 1998, 95:123-133.
24. Badanich K.A., Adler K.J., Kirstein C.L. Adolescents differ from adults in cocaine conditioned place preference and cocaine-induced dopamine in the nucleus accumbens septi. Eur. J. Pharmacol. 2006, 550:95-106.
25. Banerjee P.S., Aston J., Khundakar A.A., Zetterstrom T.S. Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain. Eur. J. Neurosci. 2009, 29:465-476.
26. Barkley R.A., Fischer M., Smallish L., Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 2003, 111:97-109.
27. Bava S., Jacobus J., Mahmood O., Yang T.T., Tapert S.F. Neurocognitive correlates of white matter quality in adolescent substance users. Brain Cogn. 2010, 72:347-354.
28. Berridge K.C. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl.) 2007, 191:391-431.
29. Berridge K.C., Robinson T.E., Aldridge J.W. Dissecting components of reward: 'liking', 'wanting', and learning. Curr. Opin. Pharmacol. 2009, 9:65-73.
30. Beuzen A., Belzung C. Link between emotional memory and anxiety states: a study by principal component analysis. Physiol. Behav. 1995, 58:111-118.
31. Blakemore S.J. The social brain in adolescence. Nat. Rev. 2008, 9:267-277.
32. Bogle K.E., Smith B.H. Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr. Drug Abuse Rev. 2009, 2:157-176.
33. Bolanos C.A., Barrot M., Berton O., Wallace-Black D., Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol. Psychiatry 2003, 54:1317-1329.
34. Bolanos C.A., Garmsen G.M., Clair M.A., McDougall S.A. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat. Eur. J. Pharmacol. 1996, 317:1-8.
35. Bolanos C.A., Glatt S.J., Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Brain Res. 1998, 111:25-33.
36. Bonaventure P., Kelly L., Aluisio L., Shelton J., Lord B., Galici R., Miller K., Atack J., Lovenberg T.W., Dugovic C. Selective blockade of 5-HT(7) receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J. Pharmacol. Exp. Ther. 2007, 321:690-698.
37. Brandon C.L., Marinelli M., Baker L.K., White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 2001, 25:651-661.
38. Brandon C.L., Marinelli M., White F.J. Adolescent exposure to methylphenidate alters activity of rat midbrain dopamine neurons. Biol. Psychiatry 2003, 54:1338-1344.
39. Brandon C.L., Steiner H. Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci. 2003, 18:1584-1592.
40. Brown R.T., Amler R.W., Freeman W.S., Perrin J.M., Stein M.T., Feldman H.M., Pierce K., Wolraich M.L. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics 2005, 115:e749-757.
41. Brown S.A., Tapert S.F. Adolescence and the trajectory of alcohol use: basic to clinical studies. Ann. N. Y. Acad. Sci. 2004, 1021:234-244.
42. Canales J.J. Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol. Learn. Mem. 2005, 83:93-103.
43. Canese R., Adriani W., Marco E.M., De Pasquale F., Lorenzini P., De Luca N., Fabi F., Podo F., Laviola G. Peculiar response to methylphenidate in adolescent compared to adult rats: a phMRI study. Psychopharmacology (Berl.) 2009, 203:143-153.
44. Cardinal R.N., Winstanley C.A., Robbins T.W., Everitt B.J. Limbic corticostriatal systems and delayed reinforcement. Ann. N. Y. Acad. Sci. 2004, 1021:33-50.
45. Carey M.P., Diewald L.M., Esposito F.J., Pellicano M.P., Gironi Carnevale U.A., Sergeant J.A., Papa M., Sadile A.G. Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav. Brain Res. 1998, 94:173-185.
46. Carlezon W.A., Mague S.D., Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol. Psychiatry 2003, 54:1330-1337.
47. Casey B.J., Giedd J.N., Thomas K.M. Structural and functional brain development and its relation to cognitive development. Biol. Psychol. 2000, 54:241-257.
48. Casey B.J., Jones R.M., Hare T.A. The adolescent brain. Ann. N. Y. Acad. Sci. 2008, 1124:111-126.
49. Caster J.M., Walker Q.D., Kuhn C.M. A single high dose of cocaine induces differential sensitization to specific behaviors across adolescence. Psychopharmacology (Berl.) 2007, 193:247-260.
50. Challman T.D., Lipsky J.J. Methylphenidate: its pharmacology and uses. Mayo Clin. Proc. 2000, 75:711-721.
51. Chambers R.A., Potenza M.N. Neurodevelopment, impulsivity, and adolescent gambling (co-sponsored by National Council on Problem Gambling and Institute for the Study of Gambling and Commercial Gaming). J. Gambl. Stud. 2003, 19:53-84.
52. Chambers R.A., Taylor J.R., Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 2003, 160:1041-1052.
53. Chau D.T., Roth R.M., Green A.I. The neural circuitry of reward and its relevance to psychiatric disorders. Curr. Psychiatry Rep. 2004, 6:391-399.
54. Chechik G., Meilijson I., Ruppin E. Neuronal regulation: a mechanism for synaptic pruning during brain maturation. Neural Comput. 1999, 11:2061-2080.
55. Chen J.G., Charles H.C., Barboriak D.P., Doraiswamy P.M. Magnetic resonance spectroscopy in Alzheimer's disease: focus on N-acetylaspartate. Acta Neurol. Scand. 2000, 176:20-26.
56. Chen Y.C., Galpern W.R., Brownell A.L., Matthews R.T., Bogdanov M., Isacson O., Keltner J.R., Beal M.F., Rosen B.R., Jenkins B.G. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn. Reson. Med. 1997, 38:389-398.
57. Christakou A., Robbins T.W., Everitt B.J. Functional disconnection of a prefrontal cortical-dorsal striatal system disrupts choice reaction time performance: implications for attentional function. Behav. Neurosci. 2001, 115:812-825.
58. Christakou A., Robbins T.W., Everitt B.J. Prefrontal cortical-ventral striatal interactions involved in affective modulation of attentional performance: implications for corticostriatal circuit function. J. Neurosci. 2004, 24:773-780.
59. Chugani H.T., Phelps M.E., Mazziotta J.C. Positron emission tomography study of human brain functional development. Ann. Neurol. 1987, 22:487-497.
60. Contractor A., Sailer A.W., Darstein M., Maron C., Xu J., Swanson G.T., Heinemann S.F. Loss of kainate receptor-mediated heterosynaptic facilitation of mossy-fiber synapses in KA2-/- mice. J. Neurosci. 2003, 23:422-429.
61. Contractor A., Swanson G., Heinemann S.F. Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron 2001, 29:209-216.
62. Dalley J.W., Cardinal R.N., Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci. Biobehav. Rev. 2004, 28:771-784.
63. Dalley J.W., Theobald D.E., Eagle D.M., Passetti F., Robbins T.W. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 2002, 26:716-728.
64. De Bellis M.D., Keshavan M.S., Beers S.R., Hall J., Frustaci K., Masalehdan A., Noll J., Boring A.M. Sex differences in brain maturation during childhood and adolescence. Cereb. Cortex 2001, 11:552-557.
65. De Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict. Biol. 2009, 14:22-31.
66. Diekhof E.K., Falkai P., Gruber O. Functional neuroimaging of reward processing and decision-making: a review of aberrant motivational and affective processing in addiction and mood disorders. Brain Res. Rev. 2008, 59:164-184.
67. Dixon A.L., Prior M., Morris P.M., Shah Y.B., Joseph M.H., Young A.M. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 2005, 48:236-245.
68. Doremus-Fitzwater T.L., Varlinskaya E.I., Spear L.P. Motivational systems in adolescence: possible implications for age differences in substance abuse and other risk-taking behaviors. Brain Cogn. 2009, 72:114-123.
69. Dwyer J.B., McQuown S.C., Leslie F.M. The dynamic effects of nicotine on the developing brain. Pharmacol. Ther. 2009, 122:125-139.
70. Easton N., Marshall F., Fone K., Marsden C. Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast. Neuropharmacology 2007, 52:812-826.
71. Easton N., Shah Y.B., Marshall F.H., Fone K.C., Marsden C.A. Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast. Psychopharmacology (Berl.) 2006, 189:369-385.
72. Ellickson P.L., Tucker J.S., Klein D.J. High-risk behaviors associated with early smoking: results from a 5-year follow-up. J. Adolesc. Health 2001, 28:465-473.
73. Eshel N., Nelson E.E., Blair R.J., Pine D.S., Ernst M. Neural substrates of choice selection in adults and adolescents: development of the ventrolateral prefrontal and anterior cingulate cortices. Neuropsychologia 2007, 45:1270-1279.
74. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berl.) 1999, 146:348-361.
75. Evenden J.L., Ryan C.N. The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl.) 1996, 128:161-170.
76. Faeh D., Viswanathan B., Chiolero A., Warren W., Bovet P. Clustering of smoking, alcohol drinking and cannabis use in adolescents in a rapidly developing country. BMC Public Health 2006, 6:169.
77. Febo M., Segarra A.C., Nair G., Schmidt K., Duong T.Q., Ferris C.F. The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 2005, 30:936-943.
78. Fletcher P.J., Tenn C.C., Sinyard J., Rizos Z., Kapur S. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Neuropsychopharmacology 2007, 32:1122-1132.
79. Floresco S.B., West A.R., Ash B., Moore H., Grace A.A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat. Neurosci. 2003, 6:968-973.
80. Frahm J., Kruger G., Merboldt K.D., Kleinschmidt A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man. Magn. Reson. Med. 1996, 35:143-148.
81. Gadian D.G. NMR and Its Applications to Living Systems 1995, Oxford University Press, Oxford, UK.
82. Gerdeman G.L., Partridge J.G., Lupica C.R., Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 2003, 26:184-192.
83. Giedd J.N. The teen brain: insights from neuroimaging. J. Adolesc. Health 2008, 42:335-343.
84. Gironi Carnevale U.A., Vitullo E., Varriale B., Ruocco L.A., Sadile A.G. A classical Mendelian cross-breeding study of the Naples high and low excitability rat lines. Behav. Brain Res. 2007, 183:130-140.
85. Guscott M., Bristow L.J., Hadingham K., Rosahl T.W., Beer M.S., Stanton J.A., Bromidge F., Owens A.P., Huscroft I., Myers J., Rupniak N.M., Patel S., Whiting P.J., Hutson P.H., Fone K.C., Biello S.M., Kulagowski J.J., McAllister G. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest a therapeutic potential in depression. Neuropharmacology 2005, 48:492-502.
86. Harel N., Lee S.P., Nagaoka T., Kim D.S., Kim S.G. Origin of negative blood oxygenation level-dependent fMRI signals. J. Cereb. Blood Flow Metab. 2002, 22:908-917.
87. Harvey R.C., Sen S., Deaciuc A., Dwoskin L.P., Kantak K.M. Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function. Neuropsychopharmacology 2011, 36:837-847.
88. Hastjarjo T., Silberberg A., Hursh S.R. Risky choice as a function of amount and variance in food supply. J. Exp. Anal. Behav. 1990, 53:155-161.
89. Hechtman L., Greenfield B. Long-term use of stimulants in children with attention deficit/hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr. Drugs 2003, 5:787-794.
90. Hendley E.D., Ohlsson W.G. Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats. Am. J. Physiol. 1991, 261:H583-H589.
91. Herpertz S.C., Sass H. Emotional deficiency and psychopathy. Behav. Sci. Law 2000, 18:567-580.
92. Hewitt K.N., Shah Y.B., Prior M.J., Morris P.G., Hollis C.P., Fone K.C., Marsden C.A. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit/hyperactivity disorder. Psychopharmacology (Berl.) 2005, 180:716-723.
93. Holmes A., Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci. Biobehav. Rev. 1999, 23:971-980.
94. Johanson C.E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 1989, 41:3-52.
95. Kalsbeek A., Voorn P., Buijs R.M., Pool C.W., Uylings H.B. Development of the dopaminergic innervation in the prefrontal cortex of the rat. J. Comp. Neurol. 1988, 269:58-72.
96. Kaminski B.J., Ator N.A. Behavioral and pharmacological variables affecting risky choice in rats. J. Exp. Anal. Behav. 2001, 75:275-297.
97. Kandel D., Yamaguchi K. From beer to crack: developmental patterns of drug involvement. Am. J. Public Health 1993, 83:851-855.
98. Kandel D.B., Yamaguchi K., Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J. Stud. Alcohol 1992, 53:447-457.
99. Kelley A.E., Schochet T., Landry C.F. Risk taking and novelty seeking in adolescence: introduction to part I. Ann. N. Y. Acad. Sci. 2004, 1021:27-32.
100. Kellogg C.K., Awatramani G.B., Piekut D.T. Adolescent development alters stressor-induced Fos immunoreactivity in rat brain. Neuroscience 1998, 83:681-689.
101. Klein-Schwartz W., McGrath J. Poison centers' experience with methylphenidate abuse in pre-teens and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2003, 42:288-294.
102. La Greca A.M., Prinstein M.J., Fetter M.D. Adolescent peer crowd affiliation: linkages with health-risk behaviors and close friendships. J. Pediatr. Psychol. 2001, 26:131-143.
103. Lai S., Lai H., Page J.B., McCoy C.B. The association between cigarette smoking and drug abuse in the United States. J. Addict. Dis. 2000, 19:11-24.
104. Lambert I.H. Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochem. Res. 2004, 29:27-63.
105. Laviola G., Adriani W. Evaluation of unconditioned novelty-seeking and d-amphetamine-conditioned motivation in mice. Pharmacol. Biochem. Behav. 1998, 59:1011-1020.
106. Laviola G., Adriani W., Terranova M.L., Gerra G. Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci. Biobehav. Rev. 1999, 23:993-1010.
107. Laviola G., Macri S., Morley-Fletcher S., Adriani W. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci. Biobehav. Rev. 2003, 27:19-31.
108. Laviola G., Pascucci T., Pieretti S. Striatal dopamine sensitization to d-amphetamine in periadolescent but not in adult rats. Pharmacol. Biochem. Behav. 2001, 68:115-124.
109. Laviola G., Wood R.D., Kuhn C., Francis R., Spear L.P. Cocaine sensitization in periadolescent and adult rats. J. Pharmacol. Exp. Ther. 1995, 275:345-357.
110. Lebel C., Walker L., Leemans A., Phillips L., Beaulieu C. Microstructural maturation of the human brain from childhood to adulthood. Neuroimage 2008, 40:1044-1055.
111. Lee J.S., Kim B.N., Kang E., Lee D.S., Kim Y.K., Chung J.K., Lee M.C., Cho S.C. Regional cerebral blood flow in children with attention deficit/hyperactivity disorder: comparison before and after methylphenidate treatment. Hum. Brain Mapp. 2005, 24:157-164.
112. Lenroot R.K., Giedd J.N. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci. Biobehav. Rev. 2006, 30:718-729.
113. Leo D., Adriani W., Cavaliere C., Cirillo G., Marco E.M., Romano E., di Porzio U., Papa M., Perrone-Capano C., Laviola G. Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology. Genes Brain Behav. 2009, 8:356-368.
114. Levy F., Swanson J.M. Timing, space and ADHD: the dopamine theory revisited. Aust. N. Z. J. Psychiatry 2001, 35:504-511.
115. Lidow M.S., Goldman-Rakic P.S., Rakic P. Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10218-10221.
116. Lockwood C.A., Menter C.G., Moggi-Cecchi J., Keyser A.W. Extended male growth in a fossil hominin species. Science 2007, 318:1443-1446.
117. Macrì S., Adriani W., Chiarotti F., Laviola G. Risk-taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice. Anim. Behav. 2002, 64:541-546.
118. Marco E.M., Granstrem O., Moreno E., Llorente R., Adriani W., Laviola G., Viveros M.P. Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats. Eur. J. Pharmacol. 2007, 557:37-43.
119. Marota J.J., Mandeville J.B., Weisskoff R.M., Moskowitz M.A., Rosen B.R., Kosofsky B.E. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. Neuroimage 2000, 11:13-23.
120. McBride W.J., Bell R.L., Rodd Z.A., Strother W.N., Murphy J.M. Adolescent alcohol drinking and its long-range consequences. Studies with animal models. Recent Dev. Alcohol. 2005, 17:123-142.
121. McCabe S.E., Teter C.J., Boyd C.J., Guthrie S.K. Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J. Adolesc. Health 2004, 35:501-504.
122. Mobini S., Chiang T.J., Ho M.Y., Bradshaw C.M., Szabadi E. Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berl.) 2000, 152:390-397.
123. Montoya A.G., Sorrentino R., Lukas S.E., Price B.H. Long-term neuro-psychiatric consequences of "ecstasy" (MDMA): a review. Harv. Rev. Psychiatry 2002, 10:212-220.
124. Morrissey G., Wogar M.A., Bradshaw C.M., Szabadi E. Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on timing behaviour investigated with an interval bisection task. Psychopharmacology (Berl.) 1993, 112:80-85.
125. Muramoto S., Yamada H., Sadato N., Kimura H., Konishi Y., Kimura K., Tanaka M., Kochiyama T., Yonekura Y., Ito H. Age-dependent change in metabolic response to photic stimulation of the primary visual cortex in infants: functional MR imaging study. J. Comput. Assist. Tomogr. 2002, 26:894-901.
126. Nestler E.J. Molecular neurobiology of addiction. Am. J. Addict./Am. Acad. Psychiatr. Alcohol Addict. 2001, 10:201-217.
127. Nightingale E.O., Fischhoff B. Adolescent risk and vulnerability: an overview. J. Adolesc. Health 2002, 31:3-9.
128. Oades R.D., Sadile A.G., Sagvolden T., Viggiano D., Zuddas A., Devoto P., Aase H., Johansen E.B., Ruocco L.A., Russell V.A. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and their interactive roles. Dev. Sci. 2005, 8:122-131.
129. Okamoto K. Spontaneous hypertension in rats. Int. Rev. Exp. Pathol. 1969, 7:227-270.
130. Palanza P., Gioiosa L., Parmigiani S. Social stress in mice: gender differences and effects of estrous cycle and social dominance. Physiol. Behav. 2001, 73:411-420.
131. Panksepp J. The ontogeny of play in rats. Dev. Psychobiol. 1981, 14:327-332.
132. Papa M., Diewald L., Carey M.P., Esposito F.J., Gironi Carnevale U.A., Sadile A.G. A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo and a posterior hyperfunctioning mesocorticolimbic system. Behav. Brain Res. 2002, 130:171-179.
133. Papa M., Sellitti S., Sadile A.G. Remodeling of neural networks in the anterior forebrain of an animal model of hyperactivity and attention deficit as monitored by molecular imaging probes. Neurosci. Biobehav. Rev. 2000, 24:149-156.
134. Papa M., Sergeant J.A., Sadile A.G. Reduced transduction mechanisms in the anterior accumbal interface of an animal model of attention-deficit/hyperactivity disorder. Behav. Brain Res. 1998, 94:187-195.
135. Perry J.L., Carroll M.E. The role of impulsive behavior in drug abuse. Psychopharmacology (Berl.) 2008, 200:1-26.
136. Piper B.J. A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicol. Teratol. 2007, 29:288-300.
137. Preece M.A., Sibson N.R., Raley J.M., Blamire A., Styles P., Sharp T. Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain. Synapse 2007, 61:925-932.
138. Primus R.J., Kellogg C.K. Pubertal-related changes influence the development of environment-related social interaction in male rats. Dev. Psychobiol. 1989, 22:633-643.
139. Ptacek R., Kuzelova H., Paclt I., Zukov I., Fischer S. ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys. Med. Sci. Monit. 2009, 15:CR595-599.
140. Puumala T., Ruotsalainen S., Jakala P., Koivisto E., Riekkinen P., Sirvio J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit/hyperactivity disorder. Neurobiol. Learn. Mem. 1996, 66:198-211.
141. Ragozzino M.E. Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns. Neurobiol. Learn. Mem. 2003, 80:257-267.
142. Rebec G.V., Christensen J.R., Guerra C., Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res. 1997, 776:61-67.
143. Rebec G.V., Grabner C.P., Johnson M., Pierce R.C., Bardo M.T. Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience 1997, 76:707-714.
144. Robbins T.W., Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr. Opin. Neurobiol. 1996, 6:228-236.
145. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47(Suppl. 1):33-46.
146. Roenneberg T., Kuehnle T., Pramstaller P.P., Ricken J., Havel M., Guth A., Merrow M. A marker for the end of adolescence. Curr. Biol. 2004, 14:R1038-1039.
147. Rogers R.D., Baunez C., Everitt B.J., Robbins T.W. Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav. Neurosci. 2001, 115:799-811.
148. Romani C., Adriani W., Manciocco A., Vitale A., Laviola G. Evaluation of impulsive behaviour in Callithrix jacchus: a pilot study. Abstract Book, V European Conference on Behavioural Biology (ECBB) 2010, 126.
149. Rother J., Knab R., Hamzei F., Fiehler J., Reichenbach J.R., Buchel C., Weiller C. Negative dip in BOLD fMRI is caused by blood flow-oxygen consumption uncoupling in humans. NeuroImage 2002, 15:98-102.
150. Rubino T., Parolaro D. Long lasting consequences of cannabis exposure in adolescence. Mol. Cell. Endocrinol. 2008, 286:S108-113.
151. Ruocco L.A., de Souza Silva M.A., Topic B., Mattern C., Huston J.P., Sadile A.G. Intranasal application of dopamine reduces activity and improves attention in Naples high excitability rats that feature the mesocortical variant of ADHD. Eur. Neuropsycopharmacol. 2009, 19:693-701.
152. Ruocco L.A., Gironi Carnevale U.A., Sica A., Arra C., Topo E., Di M.A., D'Aniello A., Sadile A.G. Elevated forebrain excitatory l-glutamate, l-aspartate and d-aspartate in the Naples High-Excitability rats. Behav. Brain Res. 2009, 198:24-28.
153. Ruocco L.A., Gironi Carnevale U.A., Treno C., Sadile A.G., Melisi D., Arra C., Ibba M., Schirru C., Carboni E. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples High-Excitability rats. Behav. Brain Res. 2010, 210:99-106.
154. Sadile A.G., Pellicano M.P., Sagvolden T., Sergeant J.A. NMDA and non-NMDA sensitive [l-3H]glutamate receptor binding in the brain of the Naples high- and low-excitability rats: an autoradiographic study. Behav. Brain Res. 1996, 78:163-174.
155. Sagvolden T., Johansen E.B., Aase H., Russell V.A. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD): the predominantly hyperactive/impulsive and combined subtypes. Behav. Brain Sci. 2005, 28:397-419.
156. Sagvolden T., Johansen E.B., Woien G., Walaas S.I., Storm-Mathisen J., Bergersen L.H., Hvalby O., Jensen V., Aase H., Russell V.A., Killeen P.R., Das Banerjee T., Middleton F.A., Faraone S.V. The spontaneously hypertensive rat model of ADHD-the importance of selecting the appropriate reference strain. Neuropharmacology 2009, 57:619-626.
157. Sagvolden T., Pettersen M.B., Larsen M.C. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol. Behav. 1993, 54:1047-1055.
158. Sala C., Futai K., Yamamoto K., Worley P.F., Hayashi Y., Sheng M. Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a. J. Neurosci. 2003, 23:6327-6337.
159. Sala C., Piech V., Wilson N.R., Passafaro M., Liu G., Sheng M. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 2001, 31:115-130.
160. Salamone J.D., Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav. Brain Res. 2002, 137:3-25.
161. Salamone J.D., Correa M., Mingote S.M., Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr. Opin. Pharmacol. 2005, 5:34-41.
162. Scannevin R.H., Huganir R.L. Postsynaptic organization and regulation of excitatory synapses. Nat. Rev. 2000, 1:133-141.
163. Scheffler R.M., Hinshaw S.P., Modrek S., Levine P. The global market for ADHD medications. Health Aff. (Project Hope) 2007, 26:450-457.
164. Schmithorst V.J., Yuan W. White matter development during adolescence as shown by diffusion MRI. Brain Cogn. 2010, 72:16-25.
165. Schousboe A., Pasantes-Morales H. Role of taurine in neural cell volume regulation. Can. J. Physiol. Pharmacol. 1992, 70:S356-361.
166. Schramm-Sapyta N.L., Walker Q.D., Caster J.M., Levin E.D., Kuhn C.M. Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. Psychopharmacology (Berl.) 2009, 206:1-21.
167. Seeman P., Madras B.K. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol. Psychiatry 1998, 3:386-396.
168. Shen R.Y., Choong K.C. Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment. Biol. Psychiatry 2006, 59:635-642.
169. Shmuel A., Augath M., Oeltermann A., Logothetis N.K. Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. Nat. Neurosci. 2006, 9:569-577.
170. Sicard K.M., Duong T.Q. Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. Neuroimage 2005, 25:850-858.
171. Siqueira L.M., Brook J.S. Tobacco use as a predictor of illicit drug use and drug-related problems in Colombian youth. J. Adolesc. Health 2003, 32:50-57.
172. Sisk C.L., Foster D.L. The neural basis of puberty and adolescence. Nat. Neurosci. 2004, 7:1040-1047.
173. Slotkin T.A. Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol. Teratol. 2002, 24:369-384.
174. Slotkin T.A., MacKillop E.A., Rudder C.L., Ryde I.T., Tate C.A., Seidler F.J. Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at 6 months of age. Neuropsychopharmacology 2007, 32:1082-1097.
175. Solomon P.R., Staton D.M. Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol. Psychiatry 1982, 17:743-756.
176. Sonuga-Barke E.J. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol. Psychiatry 2005, 57:1231-1238.
177. Sowell E.R., Delis D., Stiles J., Jernigan T.L. Improved memory functioning and frontal lobe maturation between childhood and adolescence: a structural MRI study. J. Int. Neuropsychol. Soc. 2001, 7:312-322.
178. Sowell E.R., Peterson B.S., Thompson P.M., Welcome S.E., Henkenius A.L., Toga A.W. Mapping cortical change across the human life span. Nat. Neurosci. 2003, 6:309-315.
179. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
180. Spear L.P., Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev. Psychobiol. 1983, 16:83-109.
181. Stamford J.A. Development and ageing of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry. J. Neurochem. 1989, 52:1582-1589.
182. Stephens D.W., Anderson D. The adaptive value of preference for immediacy: when shortsighted rules have farsighted consequences. Behav. Ecol. 2001, 12:330-339.
183. Svetlov S.I., Kobeissy F.H., Gold M.S. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. J. Addict. Dis. 2007, 26:1-6.
184. Swanson J.M., Volkow N.D. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav. Brain Res. 2002, 130:73-78.
185. Szobot C.M., Ketzer C., Cunha R.D., Parente M.A., Langleben D.D., Acton P.D., Kapczinski F., Rohde L.A. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:423-426.
186. Szumlinski K.K., Dehoff M.H., Kang S.H., Frys K.A., Lominac K.D., Klugmann M., Rohrer J., Griffin W., Toda S., Champtiaux N.P., Berry T., Tu J.C., Shealy S.E., During M.J., Middaugh L.D., Worley P.F., Kalivas P.W. Homer proteins regulate sensitivity to cocaine. Neuron 2004, 43:401-413.
187. Tang W.X., Fasulo W.H., Mash D.C., Hemby S.E. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J. Neurochem. 2003, 85:911-924.
188. Tarazi F.I., Tomasini E.C., Baldessarini R.J. Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res. 1998, 110:227-233.
189. Tarazi F.I., Tomasini E.C., Baldessarini R.J. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: an autoradiographic study. Dev. Neurosci. 1999, 21:43-49.
190. Teicher M.H., Andersen S.L., Hostetter J.C. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res. 1995, 89:167-172.
191. Terranova M.L., Laviola G., Alleva E. Ontogeny of amicable social behavior in the mouse: gender differences and ongoing isolation outcomes. Dev. Psychobiol. 1993, 26:467-481.
192. Tirelli E., Laviola G., Adriani W. Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci. Biobehav. Rev. 2003, 27:163-178.
193. Viggiano D., Sadile A.G. Hypertrophic A10 dopamine neurons in a rat model of attention-deficit/hyperactivity disorder (ADHD). Neuroreport 2000, 11:3677-3680.
194. Viggiano D., Vallone D., Ruocco L.A., Sadile A.G. Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit/hyperactivity disorder. Neurosci. Biobehav. Rev. 2003, 27:683-689.
195. Viggiano D., Vallone D., Welzl H., Sadile A.G. The Naples high-and low excitability rats: selective breeding, behavioral profile, morphometry and molecular biology of the mesocortical dopamine system. Behav. Genet. 2002, 32:315-333.
196. Volkow N.D., Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 2003, 160:1909-1918.
197. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., Ding Y., Gatley S.J., Gifford A., Franceschi D. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 2001, 21:RC121.
198. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Franceschi D., Maynard L., Ding Y.S., Gatley S.J., Gifford A., Zhu W., Swanson J.M. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 2002, 43:181-187.
199. Wetzels J.J., Kremers S.P., Vitoria P.D., de Vries H. The alcohol-tobacco relationship: a prospective study among adolescents in six European countries. Addiction 2003, 98:1755-1763.
200. White F.J., Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998, 51:141-153.
201. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtelle R., Utzinger L., Fusillo S. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:21-31.
202. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 1996, 6:243-251.
203. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 1987, 94:469-492.
204. Wogar M.A., Bradshaw C.M., Szabadi E. Does the effect of central 5-hydroxytryptamine depletion on timing depend on motivational change?. Psychopharmacology (Berl.) 1993, 112:86-92.
205. Wolf M.E., Sun X., Mangiavacchi S., Chao S.Z. Psychomotor stimulants and neuronal plasticity. Neuropharmacology 2004, 47:61-79.
206. Wolff M.C., Leander J.D. Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology 2002, 27:421-429.
207. Yamaguchi K., Kandel D.B. Patterns of drug use from adolescence to young adulthood. II. Sequences of progression. Am. J. Public Health 1984, 74:668-672.
208. Yamaguchi K., Kandel D.B. Patterns of drug use from adolescence to young adulthood. III. Predictors of progression. Am. J. Public Health 1984, 74:673-681.
209. Yang P.B., Amini B., Swann A.C., Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res. 2003, 971:139-152.
210. Yang P.B., Swann A.C., Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res. Bull. 2006, 71:301-310.
211. Yano M., Steiner H. Methylphenidate and cocaine: the same effects on gene regulation?. Trends Pharmacol. Sci. 2007, 28:588-596.
212. Yin H.H., Knowlton B.J., Balleine B.W. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur. J. Neurosci. 2004, 19:181-189.
213. Zuckerman M. Sensation seeking: a comparative approach to a human trait. Behav. Brain Sci. 1984, 7:413-471.
214. Zwingmann C., Butterworth R. An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy. Neurochem. Int. 2005, 47:19-30.